Drug Shortage Report for VINCRISTINE SULFATE INJECTION

Last updated on 2020-06-25 History
Report ID 99955
Drug Identification Number 02143305
Brand name VINCRISTINE SULFATE INJECTION
Common or Proper name VINCRISTINE INJECTION 1MG/ML
Company Name TEVA CANADA LIMITED
Market Status MARKETED
Active Ingredient(s) VINCRISTINE SULFATE
Strength(s) 1MG
Dosage form(s) SOLUTION
Route of administration INTRAVENOUS
Packaging size 2ML
ATC code L01CA
ATC description PLANT ALKALOIDS AND OTHER NATURAL PRODUCTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2019-11-28
Estimated end date 2020-07-31
Actual end date 2020-06-24
Shortage status Resolved
Updated date 2020-06-25
Company comments Allocating to 100% of our market.
Health Canada comments
Contact Address 30 NOVOPHARM COURT
TORONTO, ONTARIO
CANADA M1B 2K9
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v18 2020-06-25 French Compare
v17 2020-06-25 English Compare
v16 2020-05-29 French Compare
v15 2020-05-29 English Compare
v14 2020-05-08 French Compare
v13 2020-05-08 English Compare
v12 2020-04-09 French Compare
v11 2020-04-09 English Compare
v10 2020-03-26 French Compare
v9 2020-03-26 English Compare
v8 2020-02-07 French Compare
v7 2020-02-07 English Compare
v6 2020-01-17 French Compare
v5 2020-01-17 English Compare
v4 2019-11-29 English Compare
v3 2019-11-28 French Compare
v2 2019-11-28 English Compare
v1 2019-11-28 English Compare